Giselle Saulnier Sholler, Dan G. Duda, Genevieve Bergendahl, David Ebb, Matija Snuderl, Theodore W. Laetsch, Jennifer Michlitsch, Derek Hanson, Michael S. Isakoff, Kevin Bielamowicz, Jacqueline Kraveka, Peter Carmeliet, Andy De Deene, Rakesh K. Jain A phase 1 dose escalation study of TB-403 in pediatric relapsed or refractory medulloblastoma, neuroblastoma, Ewing sarcoma or alveolar rhabdomyosarcoma, Oral Platform Presentation, March 2021, AACR Annual Meeting (Virtual).
